What 8 Analyst Ratings Have To Say About Insulet
Portfolio Pulse from Benzinga Insights
Over the last quarter, Insulet (NASDAQ:PODD) has received 8 analyst ratings, with 4 being somewhat bullish and 4 indifferent. The company's average 12-month price target is $305.75, a decrease of 11.49% from the previous average of $345.43.
August 10, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Insulet has received mixed analyst ratings over the last quarter, with an average 12-month price target that is lower than the previous average.
The mixed analyst ratings, with half being somewhat bullish and half indifferent, indicate uncertainty about the company's performance. The decrease in the average 12-month price target suggests that analysts expect the stock price to decrease in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100